David W. Dodick, MD
Advertisement
Director, Concussion and Headache Programs, Mayo Clinic; Chair, American Brain Foundation, IHS-Global Patient Advocacy Coalition
Articles by David W. Dodick, MD
Here: highlights from a systematic review that these authors view as a substantial step forward in establishing an evidence-based approach to migraine treatment in the acute care setting.
Advertisement
Latest Updated Articles
Therapies in Development for Acute MigraineOctober 30th 2020
Gepants for Acute Migraine: Safety & Efficacy DataOctober 30th 2020
Treating Acute Migraine in the Community SettingOctober 30th 2020
Advances in the Treatment of Acute MigraineOctober 30th 2020
Real-World Experience With Gepants for Acute MigraineOctober 30th 2020
Ubrogepant: Treatment for Acute MigraineOctober 30th 2020
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Efgartigimod Shows Non-Inferior Disability Improvement and Greater Muscle Strength Recovery Versus Plasma Exchange in Real-World GBS Study
2
The Promise and Limitations of Neurofilament Light Chain in Peripheral Nerve Disorders: Brett Morrison, MD, PhD
3
IVIg and Plasma Exchange Show Comparable Functional Outcomes in Guillain-Barre Syndrome
4
Neurofilament Light Chain Levels Track Disease Activity and Decline With Efgartigimod Treatment in CIDP
5